Site Editor

Karl D. Lewis, MD

Advertisement

Advertisement

JNCCN Spotlights

Avelumab (Bavencio)

Videos

Steven M. Horwitz, MD, on PTCL and CTCL: Trial Results on Cerdulatinib, a Dual SYK/JAK Inhibitor

News

SITC 2020: Cemiplimab for Resistant Metastatic Basal Cell Carcinoma

Medical Literature

Merkel Cell Carcinoma of the Sinonasal Mucosa: Case Report

Medical Literature

Evaluating Skin Cancer Risk Among Military Personnel

News

ASTRO 2020: Is Nodal Radiation Therapy of Benefit in Merkel Cell Carcinoma?

JNCCN Spotlights

Avelumab (Bavencio)

Theresa M. Medina, MD, on Treating Cutaneous Squamous Cell Carcinoma With Cemiplimab-rwlc

Karl D. Lewis, MD, on Selecting Patients for Treatment With Cemiplimab-rwlc

View More

Advertisement

JNCCN Spotlights

Cemiplimab-rwlc (Libtayo^®)

Cetuximab (Erbitux®) – (Non-Melanoma Skin Cancers)

Avelumab (Bavencio)

View More

More

News

SITC 2020: Cemiplimab for Resistant Metastatic Basal Cell Carcinoma

Combining Mohs Surgery and Topical Photodynamic Therapy for Facial Basal Cell Carcinoma

Autoimmune Dermatosis in a Pembrolizumab-Treated Patient With Merkel Cell Carcinoma: Case Study

ESMO 2020: Cemiplimab in Cutaneous Squamous Cell Carcinoma: Changes in Pain and Tumor Response

When Secondary Syphilis Resembles Non-Melanoma Skin Cancer: Case Study

Does Occupational UV Exposure Increase the Risk of Developing Aggressive Skin Cancer?

ASTRO 2020: Is Nodal Radiation Therapy of Benefit in Merkel Cell Carcinoma?

COVID-19, Merkel Cell Carcinoma, and Immunotherapy: Case Study

View More

Advertisement

Published

Medical Literature

First-Line Avelumab for Metastatic Merkel Cell Carcinoma

Molecular Role of Complement C3a in Cutaneous Squamous Cell Cancer

Multikinase Inhibitor Shows Activity in Aggressive Subtype of Squamous Cell Carcinoma

Update on Laser Therapies for Basal Cell Carcinoma

View More

Ongoing

CE Activities

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

View More

Available

Clinical Trials

University of Nebraska

Seidman Cancer Center

Dana-Farber Cancer Institute

Duke Cancer Institute

View More

Resources

For Your Patients

American Academy of Dermatology

Cancer<em>Care</em>

The Skin Cancer Foundation

Cancer.Net

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.